Oaktree Acquisition III Life Sciences Current Cash

The latest current cash for OACCW is $1.2M as of September 2026. That compares with $1.3M in the prior-year period — down 7.8% year over year. Investors often review this figure alongside Oaktree Acquisition III Life Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, OACCW's current cash moved from $1.3M to $1.2M — a 7.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Oaktree Acquisition III Life Sciences's operating scale or balance-sheet position.

A current cash figure of $1.2M for OACCW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting OACCW's current cash ($1.2M), review year-over-year change from $1.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.